BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  HUTCHMED Initiates Phase I Study of BTK Inhibitor HMPL-760 in Patients with Previously Treated B-Cell Non-Hodgkin Lymphoma in China

  HUTCHMED Limited has initiated a Phase I study in China of HMPL-760, a highly potent, selective, and reversible inhibitor with long target engagement against Bruton’s tyrosine kinase, including wild-type and C481S-mutated BTK.

  January 9, 2022

   · 

  6 min read
• Deals

  Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients

  Exact Sciences Corp. announced it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing.

  January 9, 2022

   · 

  5 min read
• Business

  Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook

  Rapid Micro Biosystems, Inc., an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, announced preliminary unaudited fourth quarter and full year 2021 revenue.

  January 9, 2022

   · 

  7 min read
• Business

  908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

  908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, announced preliminary, unaudited revenue for the fourth quarter and full year ended December 31, 2021.

  January 9, 2022

   · 

  3 min read
• Deals

  Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm

  Pharmaron Beijing Co., Limited announced that it has acquired Aesica Pharmaceuticals Limited from Recipharm group.

  January 9, 2022

   · 

  3 min read
• At-Home Celiac Testing Market to Expand at a 8% CAGR by 2031: Fact.MR

  Fact.MR – A Market Research and Competitive Intelligence Provider: The rising prevalence of celiac disease, as well as rising government healthcare spending, are driving demand for at-home celiac testing kits.

  January 9, 2022

   · 

  7 min read
• Forceps Market: Availability of high-quality forceps has given an impetus to the growth of the global market

  The growth of the global forceps market is largely reliant on the presence of a stellar industry for healthcare and surgical procedures.

  January 9, 2022

   · 

  5 min read
• Link Orthotics Insole Market: Increasing Incidence of Foot Deformities is expected to drive the market

  The demand within the global link orthotics insole market is rising at a stellar pace in recent times.

  January 9, 2022

   · 

  4 min read
• Patient Engagement Technology Market: Increasing focus on patients for providing advanced care to drive the market

  The global patient engagement technology market is expected to witness high growth in the coming next few years.

  January 9, 2022

   · 

  6 min read
• Superficial Radiation Therapy System Market: Rising incidence of various types of cancer to drive the market

  Despite the relevance of radiation therapy, medical scientists have continually contested its effectiveness against invasive procedures.

  January 9, 2022

   · 

  5 min read